Evidence map›Paper›PMID 33491822›Full record

ArticleJournal of medical virology2021

A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades.

Mohammad Tanvir Islam, Asm Rubayet Ul Alam, Najmuj Sakib, Mohammad Shazid Hasan, Tanay Chakrovarty, Mohammad Tawyabur, Ovinu Kibria Islam, Hassan M Al-Emran, Mohammad Iqbal Kabir Jahid, Mohammad Anwar Hossain

Abstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Visual Screening of Genetic Polymorphisms inSensors (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. DetectingHeliyon · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammad Tanvir IslamDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Asm Rubayet Ul AlamDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.ORCID 0000-0001-9295-9865
Najmuj SakibDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Mohammad Shazid HasanDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.ORCID 0000-0002-2021-4693
Tanay ChakrovartyDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Mohammad TawyaburDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Ovinu Kibria IslamDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Hassan M Al-EmranDepartment of Biomedical Engineering, Jashore University of Science and Technology, Jashore, Bangladesh.
Mohammad Iqbal Kabir JahidDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.
Mohammad Anwar HossainDepartment of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.ORCID 0000-0001-9777-0332

Funding

Jashore University of Science and Technology Research Grant FoBST-06
6 · The paper itself

Abstract

Tracing the globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) phylogenetic clades by high-throughput sequencing is costly, time-consuming, and labor-intensive. We here propose a rapid, simple, and cost-effective amplification refractory mutation system (ARMS)-based multiplex reverse-transcription polymerase chain reaction (PCR) assay to identify six distinct phylogenetic clades: S, L, V, G, GH, and GR. Our multiplex PCR is designed in a mutually exclusive way to identify V-S and G-GH-GR clade variants separately. The pentaplex assay included all five variants and the quadruplex comprised of the triplex variants alongside either V or S clade mutations that created two separate subsets. The procedure was optimized with 0.2-0.6 µM primer concentration, 56-60°C annealing temperature, and 3-5 ng/µl complementary DNA to validate on 24 COVID-19-positive samples. Targeted Sanger sequencing further confirmed the presence of the clade-featured mutations with another set of primers. This multiplex ARMS-PCR assay is a fast, low-cost alternative and convenient to discriminate the circulating phylogenetic clades of SARS-CoV-2.

Indexed as

Cost-Benefit AnalysisCOVID-19COVID-19 Nucleic Acid TestingGenotypeHumansMultiplex Polymerase Chain ReactionMutationPhylogenyReproducibility of ResultsSARS-CoV-2ARMScladeCOVID-19multiplex PCRmutationsSARS-CoV-2

Identifiers

PMID33491822
PMCPMC8014803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.